Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Satellos Bioscience, Inc.

Clinical trials sponsored by Satellos Bioscience, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill for duchenne MD enters Mid-Stage trial in young boys Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New pill for duchenne MD enters Mid-Stage trial in young boys

Disease control Recruiting now

This study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …

Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control

Last updated Sep 20, 2026 00:00 UTC